Health Care — Alle selskaper

Silv.Dh

Vrhi.Pk

Shanghai RAAS Blood Products Co Ltd

Shanghai RAAS Blood Products Co Ltd operates in the pharmaceuticals sector, generating revenue through the production and sale of blood-derived medical products. The company is classified within th…

4DMedical Ltd

4DMedical operates with a fully diluted share count of 595 million shares, with no difference between basic and diluted shares, indicating no dilution risk from stock options or convertible instrum…

Dv Biomed Co Ltd

Dv Biomed Co Ltd has a market capitalization of TWD 1,095.71 million, based on a market price of TWD 45.0 per share and 24,349,000 shares outstanding. The company's liquidity risk could not be asse…

Akso Health Group

Akso Health Group operates as a health care provider and services company, generating revenue through its disclosed customer base. The company is classified in the Health Care Providers & Services…

Erasca Inc

Erasca Inc operates in the Healthcare Diagnostics activity within the Biotechnology & Medical Research industry, generating revenue through specialized diagnostic solutions. The company is classifi…

GVS SpA

GVS SpA operates in the Health Care Equipment & Supplies industry, generating revenue through the provision of healthcare-related products and services. The company is classified under the Health C…

Mankind Pharma Ltd

Mankind Pharma Ltd operates in the pharmaceuticals industry, generating revenue through the manufacturing and distribution of pharmaceutical products. The company is classified within the Pharmaceu…

Neuca SA

Neuca SA operates in the Health Care Providers & Services sector, generating revenue through healthcare-related activities, though specific operational details are not disclosed in the available da…

Intellia Therapeutics Inc

Intellia Therapeutics Inc is a biotechnology company focused on developing CRISPR-based therapeutics, generating limited revenue from licensing and research activities while incurring significant o…

Septerna Inc

Septerna Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for inflammatory and fibrotic diseases, generating no commercial revenue while incurring significant…

Talkspace Inc

Talkspace Inc operates as a digital mental health platform, generating revenue through subscription-based therapy services and employer-sponsored benefits programs. The company is classified within…

WAVE Life Sciences Ltd

WAVE Life Sciences Ltd is a biopharmaceutical company focused on the discovery and development of novel therapies for rare diseases, primarily generating revenue from the sale of its approved produ…

Jiangsu Sihuan Bioengineering Co Ltd

Jiangsu Sihuan Bioengineering Co Ltd (000518.SZ) is currently classified as Pharmaceuticals & Medical Research within Pharmaceuticals (Healthcare). Classification confidence: 0.92 (verified market…

Basel Medical Group Ltd

Stab.Bo

Racura Oncology Ltd

Racura Oncology Ltd has an undetermined liquidity position, as no balance-sheet inputs are available and no going-concern language is present in the source documents. The company's valuation snapsh…

Singapore Institute of Advanced Medicine Holdings Ltd

Zhejiang Tianyu Pharmaceutical Co Ltd

Zhejiang Tianyu Pharmaceutical Co Ltd operates in the pharmaceuticals sector, generating revenue through the development and sale of pharmaceutical products. The company is classified within the Ph…

Mauna Kea Technologies SA

Bio-Works Technologies AB

Bio-Works Technologies AB has an equal number of basic and diluted shares outstanding, indicating no dilution risk from stock options or convertible securities. However, liquidity risk could not be…

High Tide Inc

LENZ Therapeutics Inc

LENZ Therapeutics Inc is a biotechnology company focused on the development of novel therapeutics for the treatment of rare and orphan diseases, primarily through its lead product candidate, Lenzil…

NextCell Pharma AB

NextCell Pharma AB is a biotechnology company focused on the development of cell-based therapies for the treatment of autoimmune diseases and cancer. NextCell Pharma AB is classified under the Heal…

Reviva Pharmaceuticals Holdings Inc

Reviva Pharmaceuticals Holdings Inc is a biotechnology company focused on the development and commercialization of innovative pharmaceutical products, primarily in the healthcare diagnostics sector…

Suraksha Diagnostic Ltd

Suraksha Diagnostic Ltd provides diagnostic services and operates in the healthcare facilities and services industry, generating revenue primarily through laboratory testing and related healthcare…

Vygr.O

Voyager Therapeutics operates as a biotechnology company developing therapies for rare diseases, generating revenue through licensing and collaboration agreements with partners such as Novartis and…

ISEC Healthcare Ltd

ISEC Healthcare Ltd maintains a strong liquidity position, with a current ratio of 1.72, indicating the company can cover its short-term liabilities with its short-term assets. The company's liquid…

MIRA Pharmaceuticals Inc

MIRA Pharmaceuticals Inc operates with a capital structure that is entirely equity-funded, as evidenced by a debt-to-equity ratio of 0.0 and no long-term debt. The company's liquidity position is s…

Electromed Inc

Electromed Inc designs and manufactures high-frequency chest wall oscillation (HFCWO) devices for respiratory care, generating revenue through the sale of medical equipment and related services in…

4D Molecular Therapeutics Inc

4D Molecular Therapeutics Inc is a biotechnology company that generates revenue through the development of molecular therapeutics, operating within the Health Care sector. The company is classified…

Solara Active Pharma Sciences Ltd

Structure and Liquidity Solara Active Pharma Sciences Ltd has a debt-to-equity ratio of 0.73, indicating a moderate level of leverage. The company's liquidity position is assessed as medium, with a…

bioAffinity Technologies Inc

The company maintains a strong liquidity position with $6.45 million in cash and equivalents, representing 58.8% of total assets. Its debt-to-equity ratio of 0.11 indicates a conservative capital s…

Dimerix Ltd

Dimerix operates with a strong liquidity position, as evidenced by its cash and equivalents of AUD 68.3 million, which significantly exceeds its total liabilities of AUD 77.8 million, resulting in…

Nect.Ns

The company's capital structure shows a debt-to-equity ratio of 0.61, indicating a moderate reliance on debt financing. However, the negative net income of -1,136,810,000 INR and a negative return…

Invicta Diagnostic Ltd

The company's capital structure shows no dilution risk, with basic and diluted shares outstanding being equal at 12,571,973 shares. However, liquidity risk could not be assessed due to missing bala…

Psomagen Inc

Psomagen Inc operates with a relatively conservative capital structure, as evidenced by a debt-to-equity ratio of 0.15, indicating that the company is largely equity-funded. The company maintains a…

Brainsway Ltd

Brainsway Ltd operates in the Health Care Equipment & Supplies industry, though specific product details and revenue generation mechanisms are not disclosed in the available data. The company is cl…

CG Oncology Inc

CG Oncology Inc is a clinical-stage biopharmaceutical company developing novel therapies for cancer and other diseases, generating minimal revenue primarily from licensing or research activities wh…

Hikal Ltd

Hikal Ltd maintains a debt-to-equity ratio of 0.61, indicating a relatively balanced capital structure with moderate leverage. The company's liquidity position is assessed as medium, with a current…

Ngl Fine Chem Ltd

Ngl Fine Chem Ltd maintains a relatively strong liquidity position, with a current ratio of 2.46, indicating that the company has more than twice as many current assets as current liabilities. Howe…

Vaxcyte Inc

Vaxcyte Inc is a biotechnology company developing protein-based vaccines, operating with a negative operating income of -923,675,000 USD and a net income of -766,628,000 USD in the latest period. T…

Dicot Pharma AB

Dicot Pharma AB operates with a capital structure that is entirely equity-funded, as evidenced by a debt-to-equity ratio of 0.0. The company's liquidity position is strong, with a current ratio of…

LTR Pharma Ltd

LTR Pharma operates with a strong equity base, as evidenced by a total equity of AUD 31.51 million and a debt-to-equity ratio of 0.0, indicating no long-term debt obligations. The company's liquidi…

Mekophar Chemical Pharmaceutical JSC

Mekophar Chemical Pharmaceutical JSC has a capital structure with no long-term debt and a debt-to-equity ratio of 0.0, indicating a conservative leverage position. The company's liquidity is charac…

Genexine Inc

Genexine Inc operates with a capital structure that is heavily equity-funded, as evidenced by a debt-to-equity ratio of 0.44, which is below the industry median of 0.65. The company maintains a liq…

Cyfuse Biomedical KK

Cyfuse Biomedical KK maintains a strong liquidity position, with cash and equivalents amounting to ¥3.56 billion, significantly exceeding its total liabilities of ¥909 million, resulting in a curre…

Medicamen Biotech Ltd

Medicamen Biotech Ltd maintains a relatively conservative capital structure, with a debt-to-equity ratio of 0.15, indicating a low reliance on debt financing. The company's liquidity position is ch…

Rgen.O

The company's gross margin is expected to remain stable due to consistent cost management and pricing power in its core markets. Research and development expenditures are projected to stay within h…

Fuso Pharmaceutical Industries Ltd

Fuso Pharmaceutical Industries Ltd maintains a relatively conservative capital structure, with a debt-to-equity ratio of 0.35, indicating a moderate reliance on debt financing. The company's liquid…

Bdhi.Bo

BDHI maintains a strong liquidity position, with a current ratio of 3.95, indicating the company can easily cover its short-term liabilities with its current assets. The company's liquidity_fpt sco…

LSL Pharma Group Inc

LSL Pharma Group Inc has a highly leveraged capital structure, with a debt-to-equity ratio of 1.88, indicating that the company is financed more by debt than equity. The company's liquidity positio…

Pomina Steel Corp

Pomina Steel Corp exhibits a highly leveraged capital structure, with a debt-to-equity ratio of 5.36, significantly above the industry median. The company's liquidity position is weak, as evidenced…

Windlas Biotech Ltd

Windlas Biotech Ltd maintains a conservative capital structure, with a debt-to-equity ratio of 0.06, significantly below the industry median for pharmaceutical firms. The company's liquidity positi…

ZIM Laboratories Ltd

ZIM Laboratories Ltd maintains a debt-to-equity ratio of 0.47, indicating a relatively conservative capital structure with a moderate reliance on debt financing. The company's liquidity position is…

Citi Pharma Ltd

Citi Pharma Ltd operates in the pharmaceuticals sector, generating revenue through the manufacturing and sale of pharmaceutical products. The company is classified within the Pharmaceuticals indust…

MedNation AG

The company operates in the healthcare sector, providing pharmaceutical products and related services, generating revenue primarily through the sale of its pharmaceutical offerings. The company is…

Otsuka Pakistan Ltd

Otsuka Pakistan Ltd operates with a debt-to-equity ratio of 1.37, indicating a moderate reliance on debt financing relative to equity. The company's liquidity position is assessed as medium, with a…

Oxph.Bo

OXPH.BO's capital structure is highly leveraged, with total liabilities of ₹1,084.45 million and total equity of -₹250.25 million, resulting in a debt-to-equity ratio of -2.49. The company's liquid…

Panchsheel Organics Ltd

Panchsheel Organics Ltd maintains a strong liquidity position, with a current ratio of 3.49 and cash and equivalents of INR 218.47 million, which is well above the industry median for liquidity cov…

Arich Enterprise Co Ltd

Arich Enterprise Co Ltd maintains a strong liquidity position, with a current ratio of 1.38, indicating the company can cover its short-term liabilities with its short-term assets. The company's li…

AP Biosciences Inc

AP Biosciences Inc maintains a strong liquidity position, with cash and equivalents amounting to TWD 700 million, representing a significant portion of its total assets of TWD 1.37 billion. The com…

Birzeit Pharmaceutical Company Ltd

Birzeit Pharmaceutical Company Ltd has a strong liquidity position, as evidenced by a current ratio of 8.37, indicating that the company holds significantly more current assets than current liabili…

Fero.Psx

FERO.PSX maintains a relatively balanced capital structure, with a debt-to-equity ratio of 0.35, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as me…

Kohjin Bio Co Ltd

Kohjin Bio maintains a relatively balanced capital structure, with a debt-to-equity ratio of 0.74, indicating moderate leverage. The company holds JPY 1.73 billion in cash and equivalents, but this…

Carl Zeiss Meditec AG

Carl Zeiss Meditec maintains a conservative capital structure with a debt-to-equity ratio of 0.25, indicating a relatively low reliance on debt financing. The company's liquidity position is charac…

GeneBioTech Co Ltd

GeneBioTech maintains a conservative capital structure with a debt-to-equity ratio of 0.28, significantly below the median for the biotechnology industry, indicating a low reliance on debt financin…

Ethk Labs Inc

Ethk Labs Inc maintains a capital structure with a debt-to-equity ratio of 0.62, indicating a moderate reliance on debt financing relative to equity. The company's liquidity position is characteriz…

Adagene Inc

Adagene maintains a strong liquidity position with $74.5 million in cash and equivalents, significantly exceeding its total liabilities of $26.4 million, resulting in a current ratio of 3.07. The c…

Biomind Labs Inc

Biomind Labs Inc has a highly leveraged capital structure, with total liabilities of $1.71 billion and total equity of -$1.64 billion, resulting in a debt-to-equity ratio of -0.54. The company's li…

Wanbury Ltd

Wanbury Ltd operates with a capital structure that is heavily leveraged, as evidenced by a debt-to-equity ratio of 4.17, which is significantly higher than the industry median. The company's liquid…

Stella Pharma Corp

Stella Pharma Corp maintains a strong liquidity position, with cash and equivalents amounting to ¥20.53 billion, significantly exceeding its total liabilities of ¥14.44 billion, resulting in a curr…

Hester Biosciences Ltd

Hester Biosciences Ltd maintains a relatively balanced capital structure, with a debt-to-equity ratio of 0.84, indicating moderate leverage. The company's liquidity position is characterized as med…

Mkrs.Bo

MKRS.BO maintains a conservative capital structure with a debt-to-equity ratio of 0.07, indicating minimal reliance on debt financing. The company's liquidity position is characterized as medium ri…

Orion Infusion Ltd

Orion Infusion Ltd maintains a debt-to-equity ratio of 0.98, indicating a balanced capital structure with moderate leverage. The company's liquidity position is assessed as medium, with a current r…

Rani Zim Shopping Centers Ltd

The company maintains a capital structure with a debt-to-equity ratio of 2.11, indicating a significant reliance on debt financing. Liquidity is constrained, as evidenced by a current ratio of 0.8,…

Sakar Healthcare Ltd

Sakar Healthcare Ltd maintains a relatively conservative capital structure, with a debt-to-equity ratio of 0.3, indicating a low reliance on debt financing. The company's liquidity position is char…

145020.Kq

1515.Hk

1515.HK operates in the Health Care Providers & Services industry, generating revenue through healthcare-related activities, though specific operational details are unclassified in the available da…

Abvx.O

AirSculpt Technologies Inc

AirSculpt Technologies Inc operates in the Health Care Providers & Services industry, delivering health care services and products. The company is classified under the Health Care sector and Health…

Aktis Oncology Inc

Aktis Oncology Inc is a biotechnology company operating in the Health Care sector, focused on oncology research and development. The company is classified under the Biotechnology industry within th…

BridgeBio Oncology Therapeutics Inc

BridgeBio Oncology Therapeutics Inc is a biotechnology company operating in the Health Care sector, focused on developing oncology therapeutics. The company is classified under the Biotechnology in…

Dianthus Therapeutics Inc

Dianthus Therapeutics Inc is a biotechnology company operating in the Health Care sector, currently generating minimal revenue while incurring significant operating losses consistent with early-sta…

Bright Minds Biosciences Inc

Bright Minds Biosciences Inc is a biotechnology company operating in the Health Care sector, engaged in biotechnology activities. The company is classified under the Biotechnology industry within t…

Dyne Therapeutics, Inc

Dyne Therapeutics, Inc. is a biotechnology company operating within the Health Care sector, focused on developing therapeutic solutions, though specific product details are not provided in the avai…

Eikon Therapeutics Inc

Eikon Therapeutics Inc operates in the Healthcare Diagnostics activity within the Biotechnology & Medical Research industry, generating no reported revenue in the latest period while incurring sign…

Idya.O

Ideaya Biosciences Inc operates in the biotechnology sector within the Health Care industry, though specific business activities and revenue generation mechanisms are not detailed in the available…

Ikt.O

IKT.O is a biotechnology company within the Health Care sector, currently operating with zero revenue and negative net income, relying on cash reserves to fund operations. The company is classified…

Imcr.O

Immunocore Holdings PLC is a biotechnology company operating within the Health Care sector, though specific product or revenue-generating activities are not detailed in the available data. The comp…

Imnm.O

Immunome Inc. is a biotechnology company operating within the Health Care sector, though specific business activities and revenue generation mechanisms are not detailed in the available data. The c…

Insp.K

Inspire Medical Systems Inc (INSP.K) operates in the Health Care Equipment & Supplies industry, generating revenue through the sale of medical devices and related services. The company is classifie…

OPC Pharmaceutical JSC

OPC Pharmaceutical JSC operates in the pharmaceuticals industry within the Health Care sector, generating revenue through the production and sale of pharmaceutical products. The company is classifi…

Rlay.O

Relay Therapeutics Inc operates in the biotechnology sector within the Health Care industry, though specific business activities and revenue generation mechanisms are not detailed in the available…

Svra.O

SVRA.O is a biotechnology company within the Health Care sector, though its specific operational activities and revenue generation mechanisms are not detailed in the available data. The company is…

Wai Yuen Tong Medicine Holdings Ltd

Alpa.Ns

ALPA.NS has a fully diluted share count of 21,040,600 shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or convertible securiti…

Bioventus Inc

The company maintains a debt-to-equity ratio of 1.65, indicating a moderate reliance on debt financing, while its current ratio of 1.7 suggests adequate short-term liquidity to cover obligations. F…

Orient Bio Inc

Orient Bio Inc maintains a strong liquidity position, with a current ratio of 14.02, indicating a significant buffer of current assets relative to current liabilities. The company's cash and equiva…

Bioptik Technology Inc

The company maintains a conservative capital structure with a debt-to-equity ratio of 0.6, below the industry median of 0.8, indicating lower leverage risk. Despite holding $385.6 million in cash a…

Vectorite Biomedical Inc

Vectorite Biomedical Inc has an equal number of basic and diluted shares outstanding, with 43,771,000 shares in both categories, indicating no immediate dilution pressure from stock options or conv…

Compugen Ltd

Compugen maintains a strong liquidity position, with $90.6 million in cash and equivalents, representing 57.9% of total assets. The company has no long-term debt, and its debt-to-equity ratio is 0.…

Hemant Surgical Industries Ltd

Hemant Surgical Industries Ltd has a basic and diluted share count of 13,038,400 shares outstanding, indicating no dilution from potential share issuance at this time. However, the liquidity risk c…

Kwality Pharmaceuticals Ltd

Kwality Pharmaceuticals Ltd maintains a relatively conservative capital structure, with a debt-to-equity ratio of 0.43, indicating a moderate reliance on debt financing. The company's liquidity pos…

Promimic AB

Promimic AB operates with a capital structure that is entirely equity-funded, as evidenced by a debt-to-equity ratio of 0.0. The company maintains a strong liquidity position, with a current ratio…

Adani Total Gas Ltd

Adani Total Gas maintains a debt-to-equity ratio of 0.46, indicating a relatively conservative capital structure compared to the industry median of 0.62. However, the company's current ratio of 0.6…

Morepen Laboratories Ltd

Morepen Laboratories Ltd maintains a conservative capital structure, with a debt-to-equity ratio of 0.09, indicating a low reliance on debt financing. The company's liquidity position is characteri…

Anhui Wanbang Pharmaceutical Technology Co Ltd

The company maintains a strong liquidity position, with a current ratio of 20.34 and no long-term debt, supported by CNY 175.3 million in cash and equivalents. This liquidity is further reinforced…

Albert David Ltd

Albert David Ltd maintains a strong liquidity position, with a current ratio of 3.75, indicating the company can easily cover its short-term liabilities with its short-term assets. The company's li…

Clever Culture Systems Ltd

Clever Culture Systems Ltd has a fully diluted share count of 2,177,122,833, with no difference between basic and diluted shares outstanding, indicating no immediate dilution risk from stock option…

Haleos Labs Ltd

Haleos Labs Ltd maintains a debt-to-equity ratio of 0.57, indicating a moderate reliance on debt financing relative to equity. The company's liquidity position is characterized as medium, with a cu…

YD Bio Ltd

YD Bio Ltd has a fully diluted share count of 70.83 million shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or convertible se…

PRISM BioLab Co Ltd

PRISM BioLab maintains a strong liquidity position, with cash and equivalents amounting to ¥29.6 billion, significantly exceeding its total liabilities of ¥7.75 billion, resulting in a current rati…

Mabpharm Ltd

Mabpharm's capital structure is characterized by a lack of detailed liquidity metrics, as no balance-sheet inputs are available and no going-concern language is present in the source documents. Thi…

Yestar Healthcare Holdings Co Ltd

UXN Co Ltd

Novartis India Ltd

The company maintains a strong liquidity position, with a current ratio of 5.25 and cash and equivalents of ₹490 million, indicating a robust ability to meet short-term obligations. The low debt-to…

Moogene Medi Co Ltd

Moogene Medi Co Ltd has a fully diluted share count of 10,051,978 shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or converti…

China Biotech Services Holdings Ltd

China Biotech Services Holdings Ltd operates with a fully diluted share count equal to its basic share count of 975.73 million shares, indicating no dilution from stock options or convertible instr…

Unihealth Hospitals Ltd

Unihealth Hospitals Ltd has a basic capital structure with no dilution risk, as the number of basic and diluted shares outstanding is identical at 15,699,952. However, liquidity risk could not be a…

Cessatech A/S

Ste Promotion Pharmaceutique du Maghreb SA

(a) Capital Structure and Liquidity: The company has a basic and diluted share count of 1,000,000 shares outstanding, indicating no immediate dilution pressure from share-based compensation or conv…

Bayzed Health Group Inc

Bayzed Health Group Inc has a basic and diluted share count of 1,318,466,823 shares outstanding, indicating no immediate dilution pressure from share-based compensation or convertible instruments.…

IMBiologics Corp

IMBiologics Corp has a fully diluted share count of 14,776,110, matching its basic share count, indicating no dilution from stock options or other convertible instruments. However, the company's li…

Argenica Therapeutics Ltd

Argenica Therapeutics operates with a fully diluted share count of 128,456,712 shares, with no additional shares outstanding in the diluted structure, indicating no immediate dilution pressure from…

Genedrive PLC

Genedrive operates with a fully diluted share count of 1,605,568,256 shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or conve…

Ivision Tech SpA

Ivision Tech SpA has a fully diluted share count of 7,912,406 shares, with no difference between basic and diluted shares outstanding, indicating no dilution from stock options or convertible secur…

Daewoong Pharma

Daewoong Pharma operates in the pharmaceuticals sector, generating revenue through the development and sale of pharmaceutical products. The company is classified within the Pharmaceuticals industry…

Clover Biopharmaceuticals Ltd

Clover Biopharmaceuticals Ltd has a fully diluted share count of 1,298,233,804 shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock option…

Hua Medicine

QingSong Health Corp

QingSong Health Corp has a fully diluted share count of 206,374,209 shares, with no difference between basic and diluted shares, indicating no dilution risk from stock options or convertible instru…

Balx.Ns

BALX.NS: Business Summary BALX.NS operates in the Pharmaceuticals & Medical Research industry, focusing on the development, manufacturing, and distribution of pharmaceutical products. # BALX.NS: Cl…

Cnc.Hno

CNC.HNO: Business Summary CNC.HNO is a pharmaceutical company that generates revenue primarily through the development, production, and sale of prescription medications and related healthcare produ…

IDT Australia Ltd

IDT Australia Ltd operates in the pharmaceuticals sector, generating revenue through its healthcare-related activities. The company is classified under the Health Care economic sector and Pharmaceu…

Leef Brands Inc

Leef Brands Inc is a company in the Pharmaceuticals & Medical Research industry, primarily engaged in the development and distribution of personal care products within the healthcare sector. Leef B…

Me Today Ltd

Merck Tbk PT

Merck Tbk PT operates in the pharmaceuticals industry within the Health Care sector, generating revenue through disclosed business activities. The company is classified under the Pharmaceuticals in…

ME Therapeutics Holdings Inc

ME Therapeutics Holdings Inc is a biotechnology company focused on healthcare diagnostics, developing and commercializing diagnostic solutions for medical applications. The company is classified un…

Premium Brands Holdings Corp

Premium Brands Holdings Corp operates in the Food Products industry within the Consumer Staples sector, generating revenue through the sale of branded food items. The company is classified under th…

Vir Biotechnology Inc

Vir Biotechnology Inc is a biotechnology company focused on developing therapeutic antibodies, generating revenue primarily from licensing and collaboration agreements rather than product sales. Th…

Aashka Hospitals Ltd

Aashka Hospitals Ltd has a basic and diluted share count of 23.4 million shares, indicating no immediate dilution pressure from share issuance. However, the liquidity risk remains unassessed due to…

Morison Industries PLC

Beta Drugs Ltd

(a) Capital structure and liquidity for Beta Drugs Ltd show no dilution risk, as shares outstanding remain unchanged between basic and diluted shares. However, liquidity risk could not be assessed…